Contemporary Tailored Oncology Treatment of Biliary Tract Cancers
Biliary tract cancers (BTCs) are poor prognosis malignancies with limited treatment options. Capecitabine has recently emerged as an effective agent in the adjuvant setting; however, treatment of advanced disease is still limited to first-line cisplatin and gemcitabine chemotherapy. Recent global ef...
Spremljeno u:
| Glavni autori: | , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Wiley
2019-01-01
|
| Serija: | Gastroenterology Research and Practice |
| Online pristup: | http://dx.doi.org/10.1155/2019/7698786 |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|